Therapy development inspired by patients

Rare Disease Symposium April 18th

On Thursday April 18, Treeway’s CEO Inez de Greef is a speaker at the Rare Diseases Symposium. The second edition of the Rare Disease Symposium, organized by HollandBIO, is about challenging the status quo and the development of orphan drugs. Inez will talk about...

Treeway Announces Promising Data from Phase I Clinical Trial of Lead

–Study suggests that novel oral formulation of edaravone improves bioavailability while remaining well tolerated–  Rotterdam, The Netherlands, May 29th2018 – Treeway, a biotech company developing therapies against amyotrophic lateral sclerosis (ALS), today announced...

Australian Motor Neurone Disease Symposium

This week, the Australian Motor Neurone Disease Symposium takes place in Melbourne, Australia. Our CEO, Inez de Greef-van der Sandt, will present the clinical development of TW001 by Treeway...

ALS SYMPOSIUM: Samen tegen ALS. Samen voor de patiënt.

Op maandag 9 april wordt in samenwerking met het Jeroen Bosch Ziekenhuis een maatschappelijk symposium georganiseerd rondom het thema ALS. Vanuit drie invalshoeken zal het thema worden geduid. Inez de Greef, CEO van Treeway, zal spreken over de zoektocht naar een...